Loading
Latest filing published 09 Dec 2024 for IMPACT BIOMEDICAL INC., €1,074.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Frank D. Heuszel across 3 companies, led by Impact Biomedical Inc., DSS, Inc. and SHARING SERVICES GLOBAL Corp. Between 23 July 2019 and 5 December 2024, the trades on record add up to 8 filings.
Every open-market trade on record is a purchase: 4 purchases worth €4,940, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants. Since January 2024: 4 purchases and no sales on the market.
Half of the purchases are above €1,242 and half below. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 9 December 2024, reports an open-market purchase of €1,074 in Impact Biomedical Inc. Filings reach the SEC (Form 4) feed a median of 7 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations